… c irregularities which may be fatal. Should hyperkalaemia develop Aldactone should be discontinued, and if necessary, active measures taken to reduce the serum potassium to normal (see section 4.3).
Reversible hyperchloraemic metabolic acidosis, usually in association with hyperkalaemia has been reported to occur in some patients with decompensated hepatic cirrhosis, even in the presence of normal renal function.
Concomitant use of Aldactone with other potassium-sparing diuretics, angiotensin-converting enzyme (ACE) inhibitors, nonsteroidal anti-inflammatory drugs, angiotensin II antagonists, aldosterone blo …
Identical in all 7 labels. Surrounding text shown from Pfizer Limited.
… ontaining potassium, may lead to severe hyperkalaemia (see section 4.5).
Hyperkalaemia may also occur in patients with impaired renal function. Cardiac dysrhythmias, occasionally fatal, may result.
Reversible hyperchloraemic metabolic acidosis, usually in association with hyperkalaemia, has been reported to occur in some patients with decompensated hepatic cirrhosis, even when renal function is normal.
Dilution hyponatraemia may occur in combination with other diuretics (see section 4.5).
Hyperkalaemia in patients with severe heart failure
Hyperkalaemia may be fatal. It is critical to monitor …
Acid build-up in the blood · Spironolactone · Interchangeable?